DK0965591T3 - Fremgangsmåde til fremstilling af (S)-3-methyl-1-(2-piperidino-phenyl)-1-butylamin - Google Patents

Fremgangsmåde til fremstilling af (S)-3-methyl-1-(2-piperidino-phenyl)-1-butylamin

Info

Publication number
DK0965591T3
DK0965591T3 DK99101810T DK99101810T DK0965591T3 DK 0965591 T3 DK0965591 T3 DK 0965591T3 DK 99101810 T DK99101810 T DK 99101810T DK 99101810 T DK99101810 T DK 99101810T DK 0965591 T3 DK0965591 T3 DK 0965591T3
Authority
DK
Denmark
Prior art keywords
piperidino
butylamine
phenyl
methyl
preparation
Prior art date
Application number
DK99101810T
Other languages
English (en)
Inventor
Wolfgang Dr Dipl-Chem Grell
Andreas Dr Greischel
Gabriele Frau Dr Zahn
Michael Dr Mark
Marianne Knorr
Rupprecht Eckhard
Ulrich Dr Mueller
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36781542&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0965591(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK0965591T3 publication Critical patent/DK0965591T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK99101810T 1991-06-21 1991-06-21 Fremgangsmåde til fremstilling af (S)-3-methyl-1-(2-piperidino-phenyl)-1-butylamin DK0965591T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SG1996002715A SG43036A1 (en) 1991-06-21 1991-06-21 (S) (+) -2-ethoxy-4-[N-[1-(2-piperidino-phenyl)-3-methyl- 1-buthyl]aminocarbony methyl] - benzoic a cid
PCT/EP1991/001147 WO1993000337A1 (de) 1991-06-21 1991-06-21 (s)(+)-2-äthoxy-4-[n-[1-(2-piperidino-phenyl)-3-methyl-1-butyl]aminocarbonylmethyl]-benzoesäure
CA002111851A CA2111851C (en) 1991-06-21 1991-06-21 (s)(+)-2-ethoxy-4-[n-{1-(2-piperidino-phenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid
CN91104984A CN1048722C (zh) 1991-06-21 1991-07-22 (s)(+)-2-乙氧基-4-[n-[1-(2-哌啶子基-苯基)-3-甲基-1-丁基]氨基羰基甲基]苯甲酸,含该化合物的药物组合物及其制备方法

Publications (1)

Publication Number Publication Date
DK0965591T3 true DK0965591T3 (da) 2002-11-18

Family

ID=36781542

Family Applications (2)

Application Number Title Priority Date Filing Date
DK91911959T DK0589874T3 (da) 1991-06-21 1991-06-21 Anvendelse af (S) (+) -2-ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl ]aminocarbonylmethyl]-benzoesyre til fremstil
DK99101810T DK0965591T3 (da) 1991-06-21 1991-06-21 Fremgangsmåde til fremstilling af (S)-3-methyl-1-(2-piperidino-phenyl)-1-butylamin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK91911959T DK0589874T3 (da) 1991-06-21 1991-06-21 Anvendelse af (S) (+) -2-ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl ]aminocarbonylmethyl]-benzoesyre til fremstil

Country Status (18)

Country Link
EP (1) EP0589874B1 (da)
JP (1) JP2921982B2 (da)
KR (1) KR100496720B1 (da)
CN (1) CN1048722C (da)
AU (1) AU660930B2 (da)
BG (1) BG61690B1 (da)
CA (1) CA2111851C (da)
DE (2) DE59109151D1 (da)
DK (2) DK0589874T3 (da)
FI (1) FI106027B (da)
GR (1) GR3031654T3 (da)
NO (2) NO303687B1 (da)
PL (1) PL170210B1 (da)
RO (1) RO113462B1 (da)
SG (1) SG43036A1 (da)
SK (1) SK281246B6 (da)
UY (1) UY25923A1 (da)
WO (1) WO1993000337A1 (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE201139T1 (de) 1997-06-13 2001-06-15 Novo Nordisk As Neue dosierung für diabetes type 2
IN192862B (da) 1999-11-16 2004-05-22 Ranbaxy Lab Ltd
PE20020617A1 (es) 2000-08-22 2002-08-05 Novartis Ag Composicion que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina o un sensibilizante a la insulina
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
US20040102477A1 (en) * 2002-08-23 2004-05-27 Dr. Reddy's Laboratories Limited Polymorphic forms of (S)-Repaglinide and the processes for preparation thereof
WO2004101540A2 (de) * 2003-05-14 2004-11-25 Cilag Ag Verfahren zur herstellung von phenylessigsäurederivaten
WO2004103983A1 (en) * 2003-05-26 2004-12-02 Biocon Limited Process for the preparation of s(+)-2-ethoxy-4-[n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl]benzoic acid derivatives
WO2005021524A1 (en) * 2003-08-28 2005-03-10 Ranbaxy Laboratories Limited Process for the preparation of amorphous form of repaglinide
CN1305863C (zh) * 2004-12-27 2007-03-21 浙江大学 (s)－异丙基－(2－哌啶)苯基－甲基胺的合成方法
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
FR2898894B1 (fr) * 2006-03-24 2008-06-06 Genfit Sa Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations
US7763607B2 (en) * 2006-04-27 2010-07-27 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators
US7893080B2 (en) * 2006-10-20 2011-02-22 Neurendo Pharma, Llc Method of restoring the incretin effect
US8101769B2 (en) 2007-02-15 2012-01-24 Actavis Group Ptc Ehf Process for preparing ethyl (S)-2-ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonyl methyl]benzoate and use thereof for the preparation of Repaglinide
WO2009004485A2 (en) * 2007-06-06 2009-01-08 Actavis Group Ptc Ehf Repaglinide substantially free of dimer impurity
EP2019097A1 (en) 2007-07-25 2009-01-28 Aurobindo Pharma Limited Process for preparing (alphaS)-alpha-(2-methylpropyl)-2-(1-piperidinyl)benzenemethanamine
DK2200588T3 (da) 2007-09-25 2019-07-01 Solubest Ltd Sammensætninger, som omfatter lipofile aktive forbindelser, og fremgangsmåde til fremstilling deraf
DE102008046995B4 (de) * 2008-09-12 2010-08-26 Stada Arzneimittel Ag 2-Ethoxy-benzoesäurederivat
EP2177221A1 (en) 2008-10-20 2010-04-21 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of substantially optically pure Repaglinide and precursors thereof
US8455522B2 (en) 2009-05-15 2013-06-04 Novartis Ag Benzoxazolone derivatives as aldosterone synthase inhibitors
NZ596302A (en) 2009-05-15 2014-01-31 Novartis Ag Aryl pyridine as aldosterone synthase inhibitors
JP5466759B2 (ja) 2009-05-28 2014-04-09 ノバルティス アーゲー ネプリライシン阻害剤としての置換アミノ酪酸誘導体
SG176009A1 (en) 2009-05-28 2011-12-29 Novartis Ag Substituted aminopropionic derivatives as neprilysin inhibitors
US8519134B2 (en) 2009-11-17 2013-08-27 Novartis Ag Aryl-pyridine derivatives as aldosterone synthase inhibitors
JO2967B1 (en) 2009-11-20 2016-03-15 نوفارتس ايه جي Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
ES2472446T3 (es) 2009-11-30 2014-07-01 Novartis Ag Derivados de imidazol como inhibidores de aldosterona sintasa
EP2364977A1 (en) 2010-01-26 2011-09-14 Reuter Chemische Apparatebau KG Process for the enantiomeric enrichment of 3-methyl-1-(2-piperidinophenyl)-1-butylamine
US8673974B2 (en) 2010-11-16 2014-03-18 Novartis Ag Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
US8877815B2 (en) 2010-11-16 2014-11-04 Novartis Ag Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
CN102267959B (zh) * 2011-07-06 2013-05-01 海南锦瑞制药股份有限公司 一种瑞格列奈晶体、其制备方法及含有该晶体的固体口服制剂
CN103012319B (zh) * 2011-09-20 2015-06-10 浙江九洲药业股份有限公司 瑞格列奈中间体的合成工艺改进
CN102584743A (zh) * 2011-12-28 2012-07-18 中国药科大学 对二甲氨基吡啶瑞格列奈共晶
UY35144A (es) 2012-11-20 2014-06-30 Novartis Ag Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca
TR201808541T4 (tr) 2013-02-14 2018-07-23 Novartis Ag Nep (nötr endopeptidaz) inhibitörleri olarak ikame edilmiş bisfenil butanoik fosfonik asit türevleri.
KR20160031551A (ko) 2013-07-25 2016-03-22 노파르티스 아게 심부전의 치료를 위한 시클릭 폴리펩티드
HK1218252A1 (zh) 2013-07-25 2017-02-10 Novartis Ag 合成apelin多肽之生物结合物
US10034871B2 (en) 2014-11-07 2018-07-31 Regents Of The University Of Minnesota Salts and compositions useful for treating disease
MA41580A (fr) 2015-01-23 2017-11-29 Novartis Ag Conjugués d'acides gras de l'apeline synthétique présentant une demi-vie améliorée
WO2018034627A1 (en) 2016-08-18 2018-02-22 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Pharmaceutical composition of antidiabetic tablet
UY38072A (es) 2018-02-07 2019-10-01 Novartis Ag Compuestos derivados de éster butanoico sustituido con bisfenilo como inhibidores de nep, composiciones y combinaciones de los mismos

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3347565A1 (de) * 1983-12-30 1985-07-11 Thomae Gmbh Dr K Neue phenylessigsaeurederivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
HK1011968A1 (en) 1999-07-23
NO303687B1 (no) 1998-08-17
FI935724L (fi) 1993-12-20
RO113462B1 (ro) 1998-07-30
SK128093A3 (en) 1994-11-09
GR3031654T3 (en) 2000-02-29
DE10075006I2 (de) 2004-01-08
WO1993000337A1 (de) 1993-01-07
JP2921982B2 (ja) 1999-07-19
AU8078191A (en) 1993-01-25
PL170210B1 (pl) 1996-11-29
DE10075006I1 (de) 2000-04-20
BG61690B1 (bg) 1998-03-31
EP0589874A1 (de) 1994-04-06
CA2111851C (en) 2002-02-26
CA2111851A1 (en) 1993-01-07
DE59109151D1 (de) 1999-10-14
FI935724A0 (fi) 1993-12-20
CN1068820A (zh) 1993-02-10
AU660930B2 (en) 1995-07-13
NO934726L (no) 1993-12-20
EP0589874B1 (de) 1999-09-08
UY25923A1 (es) 2001-08-27
SK281246B6 (sk) 2001-01-18
FI106027B (fi) 2000-11-15
KR100496720B1 (ko) 2006-01-27
NO934726D0 (no) 1993-12-20
SG43036A1 (en) 1997-10-17
BG98300A (bg) 1994-09-30
DK0589874T3 (da) 2000-04-03
NO1999017I1 (no) 1999-07-20
CN1048722C (zh) 2000-01-26
JPH06508816A (ja) 1994-10-06

Similar Documents

Publication Publication Date Title
DK0965591T3 (da) Fremgangsmåde til fremstilling af (S)-3-methyl-1-(2-piperidino-phenyl)-1-butylamin
DK1275375T3 (da) Fremgangsmåde til fremstilling af aerosolsammensætninger
FI914174A7 (fi) Menetelmä piperidyylialkyyliamiinien valmistamiseksi
DK0670835T3 (da) Fremgangsmåde til fremstilling af benzopyranforbindelser
DK0768310T3 (da) Fremgangsmåde til fremstilling af imidazo-benzodiazepin-derivater
DK0535900T3 (da) Ettrinsfremgangsmåde til fremstilling af dirithromycin
DK250689A (da) Fremgangsmaade til fremstilling af napthalenderivater
DK0877738T3 (da) Fremgangsmåde til fremstilling af phenylimidazolidinderivater
DK0604060T3 (da) Fremgangsmåde til fremstilling af riboflavin
DK14589D0 (da) Fremgangsmaade til fremstilling af 1-alkyl-5-nitroimidazoler
DK30489A (da) Fremgangsmaade til fremstilling af pyranderivater
EE03027B1 (et) Meetod 8-klorokinolooni derivaatide valmistamiseks
DK0499157T3 (da) Fremgangsmåde til fremstilling af 1,3-dioxoler
DK0648738T3 (da) Fremgangsmåde til fremstilling af acetoacetarylamider
DK0648748T3 (da) Fremgangsmåde til fremstilling af 5-acetoacetylaminobenzimidazolon-2
FI913464A7 (fi) Menetelmä 1-hydroksimetyylipyratsolien valmistamiseksi
DK56694A (da) Fremgangsmåde til fremstilling af cephemderivater
DK0409321T3 (da) Fremgangsmåde til fremstilling af delta-lactoner
DK0427287T3 (da) Fremgangsmåde til fremstilling af indoler
FI923866A7 (fi) Menetelmä 1-hydroksialkyyli-5-nitroimidatsolien valmistamiseksi
FI940338L (fi) Menetelmä 13alfa-sinnamoyylibakkatiini III:n tai -10-desasetyylibakkatiini III:n valmistamiseksi
DK0621264T3 (da) Fremgangsmåde til fremstilling af arylbenzylethere
DK0377437T3 (da) Fremgangsmåde til fremstilling af 2,4-diamino-6-piperidinylpyrimidin-3-N-oxid
DK293589A (da) Fremgangsmaade til fremstiling af lactolderivater
FI913656A7 (fi) Menetelmä alkyyli-6-pyridatsiinijohdannaisten valmistamiseksi